786 related articles for article (PubMed ID: 20352091)
1. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome.
Jakobsson HE; Jernberg C; Andersson AF; Sjölund-Karlsson M; Jansson JK; Engstrand L
PLoS One; 2010 Mar; 5(3):e9836. PubMed ID: 20352091
[TBL] [Abstract][Full Text] [Related]
2. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS;
Lancet Infect Dis; 2019 Oct; 19(10):1109-1120. PubMed ID: 31559966
[TBL] [Abstract][Full Text] [Related]
3. Macrolide resistance in the normal microbiota after Helicobacter pylori treatment.
Jakobsson H; Wreiber K; Fall K; Fjelstad B; Nyrén O; Engstrand L
Scand J Infect Dis; 2007; 39(9):757-63. PubMed ID: 17701712
[TBL] [Abstract][Full Text] [Related]
4. Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans.
Wang ZJ; Chen XF; Zhang ZX; Li YC; Deng J; Tu J; Song ZQ; Zou QH
Microb Pathog; 2017 Aug; 109():156-161. PubMed ID: 28552806
[TBL] [Abstract][Full Text] [Related]
5. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
6. Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children.
Zhou Y; Ye Z; Lu J; Miao S; Lu X; Sun H; Wu J; Wang Y; Huang Y
Helicobacter; 2020 Oct; 25(5):e12721. PubMed ID: 32656891
[TBL] [Abstract][Full Text] [Related]
7. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin.
Fouhy F; Guinane CM; Hussey S; Wall R; Ryan CA; Dempsey EM; Murphy B; Ross RP; Fitzgerald GF; Stanton C; Cotter PD
Antimicrob Agents Chemother; 2012 Nov; 56(11):5811-20. PubMed ID: 22948872
[TBL] [Abstract][Full Text] [Related]
8. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.
Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Chen YH; Tsai TJ; Wu DC; Tsai KW
J Gastroenterol Hepatol; 2019 Nov; 34(11):1968-1976. PubMed ID: 31115933
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Yakoob J; Abid S; Abbas Z; Jafri SN
Br J Biomed Sci; 2010; 67(4):197-201. PubMed ID: 21294447
[TBL] [Abstract][Full Text] [Related]
11. H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota.
Martín-Núñez GM; Cornejo-Pareja I; Coin-Aragüez L; Roca-Rodríguez MDM; Muñoz-Garach A; Clemente-Postigo M; Cardona F; Moreno-Indias I; Tinahones FJ
PLoS One; 2019; 14(3):e0213548. PubMed ID: 30870471
[TBL] [Abstract][Full Text] [Related]
12. Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces.
Zaura E; Brandt BW; Teixeira de Mattos MJ; Buijs MJ; Caspers MP; Rashid MU; Weintraub A; Nord CE; Savell A; Hu Y; Coates AR; Hubank M; Spratt DA; Wilson M; Keijser BJ; Crielaard W
mBio; 2015 Nov; 6(6):e01693-15. PubMed ID: 26556275
[TBL] [Abstract][Full Text] [Related]
13. Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora.
Bühling A; Radun D; Müller WA; Malfertheiner P
Aliment Pharmacol Ther; 2001 Sep; 15(9):1445-52. PubMed ID: 11552917
[TBL] [Abstract][Full Text] [Related]
14. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.
Buckley MJ; Xia HX; Hyde DM; Keane CT; O'Morain CA
Dig Dis Sci; 1997 Oct; 42(10):2111-5. PubMed ID: 9365144
[TBL] [Abstract][Full Text] [Related]
15. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
16. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
[TBL] [Abstract][Full Text] [Related]
17. Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.
Paroni Sterbini F; Palladini A; Masucci L; Cannistraci CV; Pastorino R; Ianiro G; Bugli F; Martini C; Ricciardi W; Gasbarrini A; Sanguinetti M; Cammarota G; Posteraro B
Appl Environ Microbiol; 2016 Nov; 82(22):6633-6644. PubMed ID: 27590821
[TBL] [Abstract][Full Text] [Related]
18. Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.
Hurenkamp GJ; Van Der Ende A; Grundmeijer HG; Tytgat GN; Van Der Hulst RW
Aliment Pharmacol Ther; 2000 Aug; 14(8):1065-70. PubMed ID: 10930901
[TBL] [Abstract][Full Text] [Related]
19. [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
Labenz J; Peitz U; Tillenburg B; Becker T; Börsch G; Stolte M
Leber Magen Darm; 1995 May; 25(3):122, 125-7. PubMed ID: 7609590
[TBL] [Abstract][Full Text] [Related]
20. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
